Citi Assumes Acceleron Pharma (XLRN) at Buy
Tweet
Share
E-mailGet Alerts XLRN Hot Sheet
Price: $178.75 --0%
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 31 | New: 13
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 31 | New: 13
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Citi analyst Yigal Nochomovitz assumes coverage on Acceleron Pharma (NASDAQ: XLRN) with a Buy rating and a price target of $66.00 (from $63.00).
For an analyst ratings summary and ratings history on Acceleron Pharma click here. For more ratings news on Acceleron Pharma click here.
Shares of Acceleron Pharma closed at $41.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BWS Financial Starts Immersion (IMMR) at Buy bullish on Eric Singer as CEO
- Maxim Group Starts Interlink Electronics (LINK) at Buy
- Goldman Sachs Starts Meyer Burger Technology AG (MBTN:SW) (MYBUF) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
